Rock Springs Capital Management LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Rock Springs Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $12 Million - $15.9 Million	-203,817 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $110,731 - $283,335	3,817 Added 1.91%	203,817 $14.9 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $5.86 Million - $8.27 Million	-143,500 Reduced 41.78%	200,000 $10.9 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $3.32 Million - $5.6 Million	83,500 Added 32.12%	343,500 $15 Million
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $4.51 Million - $5.91 Million	-137,500 Reduced 34.59%	260,000 $9.76 Million
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $1.71 Million - $3.07 Million	72,500 Added 22.31%	397,500 $15.7 Million
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $1.82 Million - $2.8 Million	81,000 Added 33.2%	325,000 $8.37 Million
Q3 2017 Nov 14, 2017	BUY	$23.54 - $38.21 $5.74 Million - $9.32 Million	244,000	244,000 $9.12 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.